サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1791467

動物の血液と血液成分の世界市場

Animal Blood & Blood Components

出版日
ページ情報
英文 174 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.45円
動物の血液と血液成分の世界市場
出版日: 2025年08月15日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 174 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

動物の血液と血液成分の世界市場は2030年までに2億6,320万米ドルに達する見込み

2024年に1億5,820万米ドルと推定された動物の血液と血液成分の世界市場は、2024～2030年の分析期間にCAGR 8.9%で成長し、2030年には2億6,320万米ドルに達すると予測されます。本レポートで分析したセグメントの1つである動物の血液成分は、CAGR 10.6%を記録し、分析期間終了時には1億5,570万米ドルに達すると予想されます。動物の全血セグメントの成長率は、分析期間中CAGR 6.7%と推定されます。

米国市場は4,160万米ドルと推定される一方、中国はCAGR 8.5%で成長すると予測される

米国の動物の血液と血液成分市場は、2024年には4,160万米ドルと推定されます。世界第2位の経済大国である中国は、2024-2030年の分析期間においてCAGR 8.5%を辿り、2030年までに予測市場規模4,180万米ドルに達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ8.3％と7.3％と予測されています。欧州では、ドイツがCAGR約6.9%で成長すると予測されています。

世界の動物の血液と血液成分市場- 主要動向と促進要因のまとめ

動物の血液と血液成分の需要が様々な産業で増加しているのはなぜか？

動物の血液とその成分に対する需要は、医薬品、動物飼料、食品加工、診断など幅広い用途があるため、様々な産業で増加しています。血漿、ヘモグロビン、血清タンパク質などの動物血液誘導体のワクチン、治療製品、バイオ医薬品の生産における使用の増加は、市場成長を促進する重要な要因です。また、動物飼料産業も重要な消費者として台頭しており、血液ミールや血漿タンパク質は、家畜の栄養と成長を高めるための高タンパク栄養補助食品として使用されています。さらに食品加工業界は、豊富なアミノ酸とタンパク質含有量を利用して、機能性食品や栄養補助食品の製造に動物の血液成分を取り入れています。持続可能な資源利用に対する意識の高まりは、動物の血液製品別の革新的な用途を模索し、廃棄物を減らし、動物加工から得られる価値を最大化するよう、業界をさらに後押ししています。

技術進歩はどのように市場のイノベーションを促進しているか？

処理と分離技術における技術の進歩は、動物の血液成分の生産と応用に革命をもたらしています。分画と精製プロセスにおける技術革新は、機能的特性を強化した高価値のタンパク質と生物活性化合物の抽出を可能にし、それらをバイオテクノロジーと医薬品における特殊な用途に適したものにしています。高度な滅菌・保存技術の採用も、血液由来製品の保存期間と安定性を向上させ、エンドユーザーにとっての品質と有効性を保証しています。さらに、バイオテクノロジーと分子生物学の研究により、免疫グロブリンが豊富な血漿や動物血液由来の生物活性ペプチドなどの新規製品の開発が促進され、免疫健康、創傷治癒、栄養補助食品への応用に役立つ可能性があります。このような技術的進歩が進化を続ける中、メーカーは製品の一貫性の向上、処理コストの削減、各地域の規制要件を満たすための安全基準の強化に注力しています。

動物の血液と血液成分市場にはどのような課題と機会が存在するか？

動物の血液と血液成分市場は、規制上のハードル、倫理的懸念、原料供給のばらつきなど、いくつかの課題に直面しています。特に食品業界や製薬業界において、動物由来原料の収集、加工、使用を規定する厳しい規制の枠組みは、市場関係者にとってコンプライアンス上の課題となっています。動物福祉と血液製剤の調達に関連する倫理的懸念も、業界利害関係者に、より透明で持続可能な調達慣行の採用を促しています。さらに、汚染や疾病伝播の潜在的リスクは、厳格な品質管理対策を必要とし、業務上の複雑さをさらに増しています。しかし、これらの課題は、技術革新と市場差別化の機会を提供します。代替タンパク源への注目の高まり、クリーンラベルで持続可能な原料への需要の高まり、生体材料と再生医療における研究の拡大は、動物の血液由来製品に有望な成長手段を提供します。環境に優しい加工技術や堅牢なトレーサビリティシステムに投資する企業は、この進化する市場における新たな機会を活用するのに有利な立場にあります。

動物の血液と血液成分市場の成長を促進する主な要因は何か？

動物の血液と血液成分市場の成長は、高タンパク動物用飼料の需要増加、医薬品への応用拡大、食品加工での利用拡大など、いくつかの要因によってもたらされます。世界人口の増加と効率的な畜産へのニーズの高まりが、動物の健康と生産性を高める血液ベースの飼料添加物への需要を促進しています。製薬業界がワクチン生産、細胞培養培地、バイオ医薬品開発のために血液由来タンパク質への依存度を高めていることも、主要な促進要因です。さらに、動物の血液成分を組み込んだ機能性食品や栄養補助食品の動向の高まりも、市場拡大に寄与しています。持続可能な資源利用を促進する政府の取り組みと加工技術の進歩は、今後数年間で市場の成長をさらに加速させると予想されます。

セグメント

種類（動物の血液成分、動物の全血）、動物サイズ（大型動物、小型動物）、用途（貧血用途、外科用途、出血性疾患用途、その他用途）

調査対象企業の例

  • Animal Technologies, Inc.
  • Biowest SAS
  • Bovogen Biologicals Pty Ltd.
  • Kraeber & Co GmbH
  • Lake Immunogenics, Inc.
  • LAMPIRE Biological Laboratories, Inc.
  • PAN-Biotech GmbH
  • Pel-Freez, LLC
  • Rocky Mountain Biologicals, LLC
  • Serana Europe GmbH
  • TCS Biosciences Ltd.
  • Thermo Fisher Scientific, Inc.

AIインテグレイションズ

Global Industry Analystsは、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP29149

Global Animal Blood & Blood Components Market to Reach US$263.2 Million by 2030

The global market for Animal Blood & Blood Components estimated at US$158.2 Million in the year 2024, is expected to reach US$263.2 Million by 2030, growing at a CAGR of 8.9% over the analysis period 2024-2030. Animal Blood Components, one of the segments analyzed in the report, is expected to record a 10.6% CAGR and reach US$155.7 Million by the end of the analysis period. Growth in the Animal Whole Blood segment is estimated at 6.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$41.6 Million While China is Forecast to Grow at 8.5% CAGR

The Animal Blood & Blood Components market in the U.S. is estimated at US$41.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$41.8 Million by the year 2030 trailing a CAGR of 8.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.3% and 7.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.9% CAGR.

Global Animal Blood & Blood Components Market - Key Trends & Drivers Summarized

Why Is Demand for Animal Blood & Blood Components Increasing Across Various Industries?

The demand for animal blood and its components is rising across multiple industries due to its wide-ranging applications in pharmaceuticals, animal feed, food processing, and diagnostics. The increasing use of animal blood derivatives such as plasma, hemoglobin, and serum proteins in the production of vaccines, therapeutic products, and biopharmaceuticals is a key factor driving market growth. The animal feed industry has also emerged as a significant consumer, with blood meal and plasma proteins being used as high-protein dietary supplements to enhance livestock nutrition and growth. In addition, the food processing industry is incorporating animal blood components in the production of functional foods and nutritional supplements, leveraging their rich amino acid and protein content. The growing awareness of sustainable resource utilization is further encouraging industries to explore innovative applications of animal blood by-products, reducing waste and maximizing value from animal processing.

How Are Technological Advancements Driving Innovation in the Market?

Technological advancements in processing and separation techniques are revolutionizing the production and application of animal blood components. Innovations in fractionation and purification processes are enabling the extraction of high-value proteins and bioactive compounds with enhanced functional properties, making them suitable for specialized applications in biotechnology and pharmaceuticals. The adoption of advanced sterilization and preservation technologies is also improving the shelf life and stability of blood-derived products, ensuring their quality and efficacy for end-users. Additionally, research in biotechnology and molecular biology is facilitating the development of novel products such as immunoglobulin-rich plasma and bioactive peptides derived from animal blood, offering potential benefits for immune health, wound healing, and nutraceutical applications. As these technological advancements continue to evolve, manufacturers are focusing on improving product consistency, reducing processing costs, and enhancing safety standards to meet regulatory requirements across different regions.

What Challenges and Opportunities Exist in the Animal Blood & Blood Components Market?

The animal blood and blood components market faces several challenges, including regulatory hurdles, ethical concerns, and variability in raw material supply. Stringent regulatory frameworks governing the collection, processing, and use of animal-derived materials, particularly in the food and pharmaceutical industries, present compliance challenges for market players. Ethical concerns related to animal welfare and the sourcing of blood products have also prompted industry stakeholders to adopt more transparent and sustainable sourcing practices. Additionally, the potential risks of contamination and disease transmission require rigorous quality control measures, further adding to operational complexities. However, these challenges present opportunities for innovation and market differentiation. The increasing focus on alternative protein sources, growing demand for clean-label and sustainable ingredients, and the expansion of research in biomaterials and regenerative medicine offer promising growth avenues for animal blood-derived products. Companies investing in eco-friendly processing technologies and robust traceability systems are well-positioned to capitalize on emerging opportunities in this evolving market.

What Are the Key Factors Driving Growth in the Animal Blood & Blood Components Market?

The growth in the Animal Blood & Blood Components market is driven by several factors, including the rising demand for high-protein animal feed, expanding applications in pharmaceuticals, and increasing utilization in food processing. The growing global population and the rising need for efficient livestock production are fueling the demand for blood-based feed additives that enhance animal health and productivity. The pharmaceutical industry's increasing reliance on blood-derived proteins for vaccine production, cell culture media, and biopharmaceutical development is another major growth driver. Additionally, the growing trend of functional foods and dietary supplements incorporating animal blood components is contributing to market expansion. Government initiatives promoting sustainable resource utilization and advancements in processing technologies are expected to further accelerate market growth in the coming years.

SCOPE OF STUDY:

The report analyzes the Animal Blood & Blood Components market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Animal Blood Components, Animal Whole Blood); Animal Size (Large Animals, Small Animals); Application (Anemia Application, Surgery Application, Bleeding Disorders Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -

  • Animal Technologies, Inc.
  • Biowest SAS
  • Bovogen Biologicals Pty Ltd.
  • Kraeber & Co GmbH
  • Lake Immunogenics, Inc.
  • LAMPIRE Biological Laboratories, Inc.
  • PAN-Biotech GmbH
  • Pel-Freez, LLC
  • Rocky Mountain Biologicals, LLC
  • Serana Europe GmbH
  • TCS Biosciences Ltd.
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Animal Blood & Blood Components - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Animal-Derived Proteins in Pharmaceuticals and Biotechnology Propels Growth in the Animal Blood and Blood Components Market
    • Increasing Use of Animal Blood Plasma in Functional Foods and Nutraceuticals Expands Market Opportunities
    • Growing Demand for Blood-Derived Proteins in Cell Culture Media Strengthens Business Case for Animal Blood Components in Biopharmaceutical Research
    • Expansion of the Pet Food Industry Spurs the Use of Animal Blood Components in High-Protein and Specialty Pet Nutrition
    • Technological Advancements in Blood Fractionation and Processing Enhance the Yield and Purity of Animal Blood Components
    • Rising Adoption of Animal Blood Components in Veterinary Medicine and Diagnostics Fuels Market Expansion
    • Increasing Demand for Hemoglobin-Based Oxygen Carriers (HBOCs) Throws the Spotlight on Animal Blood as a Source of Artificial Blood Substitutes
    • Surging Interest in Sustainable and Zero-Waste Meat Processing Strengthens Utilization of Animal Blood By-Products
    • Growing Applications in the Leather Industry Propel Demand for Animal Blood-Derived Proteins in Tanning and Biopolymer Production
    • Regulatory Approvals and Quality Standards Influence Product Development and Safety Compliance in the Animal Blood Components Market
    • Increasing Use of Animal Blood Extracts in Traditional Medicine and Herbal Formulations Expands Addressable Market
    • Rising Investments in Alternative Protein Sources Encourage Research into Animal Blood-Derived Functional Ingredients
    • Growing Concerns Over Zoonotic Diseases Drive Innovations in Pathogen-Free Processing of Animal Blood and Blood Components
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Animal Blood & Blood Components Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Animal Blood & Blood Components by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Animal Blood Components by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Animal Blood Components by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Animal Whole Blood by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Animal Whole Blood by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Large Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Large Animals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Small Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Small Animals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Anemia Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Anemia Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Surgery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Surgery Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Bleeding Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Bleeding Disorders Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Animal Blood & Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Type - Animal Blood Components and Animal Whole Blood - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA 6-Year Perspective for Animal Blood & Blood Components by Type - Percentage Breakdown of Value Sales for Animal Blood Components and Animal Whole Blood for the Years 2025 & 2030
    • TABLE 22: USA Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Animal Size - Large Animals and Small Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 23: USA 6-Year Perspective for Animal Blood & Blood Components by Animal Size - Percentage Breakdown of Value Sales for Large Animals and Small Animals for the Years 2025 & 2030
    • TABLE 24: USA Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Application - Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 25: USA 6-Year Perspective for Animal Blood & Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications for the Years 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Type - Animal Blood Components and Animal Whole Blood - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada 6-Year Perspective for Animal Blood & Blood Components by Type - Percentage Breakdown of Value Sales for Animal Blood Components and Animal Whole Blood for the Years 2025 & 2030
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Animal Size - Large Animals and Small Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Canada 6-Year Perspective for Animal Blood & Blood Components by Animal Size - Percentage Breakdown of Value Sales for Large Animals and Small Animals for the Years 2025 & 2030
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Application - Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Canada 6-Year Perspective for Animal Blood & Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications for the Years 2025 & 2030
  • JAPAN
    • Animal Blood & Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Type - Animal Blood Components and Animal Whole Blood - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan 6-Year Perspective for Animal Blood & Blood Components by Type - Percentage Breakdown of Value Sales for Animal Blood Components and Animal Whole Blood for the Years 2025 & 2030
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Animal Size - Large Animals and Small Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Japan 6-Year Perspective for Animal Blood & Blood Components by Animal Size - Percentage Breakdown of Value Sales for Large Animals and Small Animals for the Years 2025 & 2030
    • TABLE 36: Japan Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Application - Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Japan 6-Year Perspective for Animal Blood & Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications for the Years 2025 & 2030
  • CHINA
    • Animal Blood & Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Type - Animal Blood Components and Animal Whole Blood - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China 6-Year Perspective for Animal Blood & Blood Components by Type - Percentage Breakdown of Value Sales for Animal Blood Components and Animal Whole Blood for the Years 2025 & 2030
    • TABLE 40: China Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Animal Size - Large Animals and Small Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 41: China 6-Year Perspective for Animal Blood & Blood Components by Animal Size - Percentage Breakdown of Value Sales for Large Animals and Small Animals for the Years 2025 & 2030
    • TABLE 42: China Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Application - Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 43: China 6-Year Perspective for Animal Blood & Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications for the Years 2025 & 2030
  • EUROPE
    • Animal Blood & Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe 6-Year Perspective for Animal Blood & Blood Components by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Type - Animal Blood Components and Animal Whole Blood - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Europe 6-Year Perspective for Animal Blood & Blood Components by Type - Percentage Breakdown of Value Sales for Animal Blood Components and Animal Whole Blood for the Years 2025 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Animal Size - Large Animals and Small Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Europe 6-Year Perspective for Animal Blood & Blood Components by Animal Size - Percentage Breakdown of Value Sales for Large Animals and Small Animals for the Years 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Application - Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Animal Blood & Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications for the Years 2025 & 2030
  • FRANCE
    • Animal Blood & Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 52: France Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Type - Animal Blood Components and Animal Whole Blood - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 53: France 6-Year Perspective for Animal Blood & Blood Components by Type - Percentage Breakdown of Value Sales for Animal Blood Components and Animal Whole Blood for the Years 2025 & 2030
    • TABLE 54: France Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Animal Size - Large Animals and Small Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 55: France 6-Year Perspective for Animal Blood & Blood Components by Animal Size - Percentage Breakdown of Value Sales for Large Animals and Small Animals for the Years 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Application - Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France 6-Year Perspective for Animal Blood & Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications for the Years 2025 & 2030
  • GERMANY
    • Animal Blood & Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 58: Germany Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Type - Animal Blood Components and Animal Whole Blood - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Germany 6-Year Perspective for Animal Blood & Blood Components by Type - Percentage Breakdown of Value Sales for Animal Blood Components and Animal Whole Blood for the Years 2025 & 2030
    • TABLE 60: Germany Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Animal Size - Large Animals and Small Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Germany 6-Year Perspective for Animal Blood & Blood Components by Animal Size - Percentage Breakdown of Value Sales for Large Animals and Small Animals for the Years 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Application - Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany 6-Year Perspective for Animal Blood & Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications for the Years 2025 & 2030
  • ITALY
    • TABLE 64: Italy Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Type - Animal Blood Components and Animal Whole Blood - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Italy 6-Year Perspective for Animal Blood & Blood Components by Type - Percentage Breakdown of Value Sales for Animal Blood Components and Animal Whole Blood for the Years 2025 & 2030
    • TABLE 66: Italy Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Animal Size - Large Animals and Small Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Italy 6-Year Perspective for Animal Blood & Blood Components by Animal Size - Percentage Breakdown of Value Sales for Large Animals and Small Animals for the Years 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Application - Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy 6-Year Perspective for Animal Blood & Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications for the Years 2025 & 2030
  • UNITED KINGDOM
    • Animal Blood & Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 70: UK Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Type - Animal Blood Components and Animal Whole Blood - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 71: UK 6-Year Perspective for Animal Blood & Blood Components by Type - Percentage Breakdown of Value Sales for Animal Blood Components and Animal Whole Blood for the Years 2025 & 2030
    • TABLE 72: UK Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Animal Size - Large Animals and Small Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 73: UK 6-Year Perspective for Animal Blood & Blood Components by Animal Size - Percentage Breakdown of Value Sales for Large Animals and Small Animals for the Years 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Application - Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK 6-Year Perspective for Animal Blood & Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 76: Rest of Europe Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Type - Animal Blood Components and Animal Whole Blood - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Rest of Europe 6-Year Perspective for Animal Blood & Blood Components by Type - Percentage Breakdown of Value Sales for Animal Blood Components and Animal Whole Blood for the Years 2025 & 2030
    • TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Animal Size - Large Animals and Small Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Rest of Europe 6-Year Perspective for Animal Blood & Blood Components by Animal Size - Percentage Breakdown of Value Sales for Large Animals and Small Animals for the Years 2025 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Application - Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Rest of Europe 6-Year Perspective for Animal Blood & Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Animal Blood & Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 82: Asia-Pacific Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Type - Animal Blood Components and Animal Whole Blood - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Asia-Pacific 6-Year Perspective for Animal Blood & Blood Components by Type - Percentage Breakdown of Value Sales for Animal Blood Components and Animal Whole Blood for the Years 2025 & 2030
    • TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Animal Size - Large Animals and Small Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Asia-Pacific 6-Year Perspective for Animal Blood & Blood Components by Animal Size - Percentage Breakdown of Value Sales for Large Animals and Small Animals for the Years 2025 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Application - Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific 6-Year Perspective for Animal Blood & Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 88: Rest of World Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Type - Animal Blood Components and Animal Whole Blood - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Rest of World 6-Year Perspective for Animal Blood & Blood Components by Type - Percentage Breakdown of Value Sales for Animal Blood Components and Animal Whole Blood for the Years 2025 & 2030
    • TABLE 90: Rest of World Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Animal Size - Large Animals and Small Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Rest of World 6-Year Perspective for Animal Blood & Blood Components by Animal Size - Percentage Breakdown of Value Sales for Large Animals and Small Animals for the Years 2025 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Animal Blood & Blood Components by Application - Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of World 6-Year Perspective for Animal Blood & Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Surgery Application, Bleeding Disorders Application and Other Applications for the Years 2025 & 2030

IV. COMPETITION